• Users Online: 4646
  • Print this page
  • Email this page
Year : 2016  |  Volume : 4  |  Issue : 1  |  Page : 28-32

A study of Bcl-2 and p-53 immunostaining expressions in colonic carcinomas

1 Consultant Pathologist, Omega Cancer Hospital, Banjara Hills, Hyderabad, India
2 Professor, Department of Pathology, Malla Reddy Institute of Medical Sciences, Hyderabad, India
3 Professor, Department of Pathology, MNJ Cancer Hospital, Osmania Medical College, Hyderabad, India
4 Assistant Professor, Department of Pathology, Malla Reddy Institute of Medical Sciences, Hyderabad, India

Correspondence Address:
K Shashi Kiran
Consultant Pathologist, Omega Cancer Hospital, Banjara Hills, Hyderabad
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2321-7006.303061

Rights and Permissions

Background: Colorectal cancer burden has been steadily rising in women. It was the fourth most common cancer in 1975 and has reached the second position by 1990, with about 49% increase in the number of cases globally over a period of 15 yrs. From 1999–2008, the rate of people dying from colorectal cancer has varied, depending on their race and ethnicity. Objective: To study Bcl-2 and p-53 immunostaining expressions in colonic carcinomas. Methods: The present study is both a retrospective and a prospective study. The study is based on histomorphological evaluation of 30 resected specimen of Colorectal Carcinomas received at the department of Pathology, Osmania General Hospital in a 2 year period from June 2009 to May 2011. The most representative block for all 30 cases was then selected for immune histochemical analysis of p-53 protein and Bcl-2 Oncoprotein for p-53 immunostaining, we used the DO-7 monoclonal antibody (dilution 1:30; DAKO), and, for Bcl-2, the monoclonal antibody 124 was used (dilution 1:80; DAKO). Results: Positive staining for p-53 protein was detected in 56.67% ( 17/30 ) of colorectal adenocarcinomas. There is statistically no significant association observed between p53 expression and Dukes' stage, TNM stage or Histological grade (p value > 0.05). Similarly no association was found between expression of p-53 and other patient variables, such as age, sex, location of tumor, & tumor differentiation. In the present study statistically there is no significant association between Bcl-2 & p-53 either individually or combined together with any of the parameters (like age, sex, tumor location, Dukes' stage, Histological grade & TNM stage). Conclusion: Though not statistically significant, to comment as the optimism expressed by certain investigators due to the low number of cases taken up for the present study, a large study group is needed to comment on the prognostic significance of the Bcl-2 & p-53 immuno profile individually and in a combined variation to predict the clinical outcome.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded91    
    Comments [Add]    

Recommend this journal